6AND
Pinatuzumab Fab in complex with anti-Kappa VHH domain
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2016-10-10 |
Detector | RAYONIX MX-300 |
Wavelength(s) | 0.97949 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 63.402, 72.947, 70.724 |
Unit cell angles | 90.00, 110.73, 90.00 |
Refinement procedure
Resolution | 46.012 - 1.750 |
R-factor | 0.2425 |
Rwork | 0.241 |
R-free | 0.28990 |
RMSD bond length | 0.003 |
RMSD bond angle | 0.690 |
Data reduction software | XPREP |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX ((1.12_2829: ???)) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 46.142 | 1.920 | 1.850 |
High resolution limit [Å] | 1.750 | 1.870 | 1.750 |
Number of reflections | 57457 | ||
<I/σ(I)> | 16.05 | ||
Completeness [%] | 93.6 | ||
Redundancy | 3.35 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 0.2 M lithium sulfate, 0.1 M HEPES pH 7.4 and 25 % polyethyleneglycol (PEG) 3350 |